Search Results
Displaying results 21 - 31 of 31
- The George Institute’s Dr Zien Zhou has been awarded almost $1,000,000 over three years to evaluate the use of brain magnetic resonance imaging (MRI) to identify ‘hidden’ changes to blood vessels in…08/3/2023 -Newsentity:node25,645.691
- Worldwide, 160 million people with type 2 diabetes have or are at risk of developing chronic kidney disease. We identified the first new treatment for diabetic kidney disease in 20 years. The…25/2/2020 -Landing Pageentity:node26,076.092
- The number of people living with diabetes is increasing worldwide at an alarming rate. According to the International Diabetes Federation (IDF), diabetes is one of the fastest growing health…13/11/2020 -Newsentity:node30,636.27
- For two decades, The George Institute has been at the forefront of global efforts to improve kidney disease treatment around the world, as Professor Vlado Perkovic explains. Vlado…12/11/2019 -Profile storyentity:node148,140.67
- The CREDENCE trial, investigating a breakthrough treatment for chronic kidney disease and type 2 diabetes, has been ended early after benefit was demonstrated at an interim analysis. The study, being…17/7/2018 -Media releaseentity:node40,036,684
- Lead author Dr Brendon Neuen from The George Institute for Global Health commented: “We found SGLT2 inhibitors clearly and powerfully reduce the risk of kidney failure.” “These findings…02/9/2019 -Media releaseentity:node40,814,624
- A new treatment for people with diabetes and kidney disease reduced kidney failure rates by a third, according to a landmark study. The results, published in the New England Journal of Medicine, also…14/4/2019 -Media releaseentity:node42,406,264
- The landmark clinical trial, CREDENCE, transformed the status quo in diabetic kidney disease research by identifying the first new treatment in almost 20 years. Building on The George Institute’s…09/3/2022 -Case Studiesentity:node1,673,210,490,000
- Standalone grabs with Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial11/4/2019 -Videoentity:node9,768,983,900,000
- 11/4/2019 -Videoentity:node9,806,700,100,000
- Professor Vlado Perkovic, of The George Institute, discusses the results of the CREDENCE kidney disease trial11/4/2019 -Videoentity:node9,883,014,400,000